drugset / Trial / NCT00002368

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

NCT00002368

Phase 3 Completed 2000 enrolled Boehringer Ingelheim
Parallel-groupTreatment

Summary

To evaluate the tolerance, safety, and effectiveness of Viramune in preventing clinical AIDS progression events or death when used in combination with Lamivudine and background nucleoside therapy.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nevirapine Small molecule
Background Lamivudine Other / unclassified